CEO: Derek T. Chalmers

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.


Key numbers

Market Capitalization:790386129
Shares Outstanding: 46796100
Float: 42384912
Next Earning Date:2020-10-29
TTm EPS: -2.5461
TTm Dividend Rate:
200 days moving average:16.67
50 days moving average: 16.72
One day percent Change: -3.01



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,